Response to Letter to the Editor: Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: A Randomized, Double-Blind, Phase 3 Study (ORIENT-11).
作者信息
Yang Yunpeng, Zhou Hui, Zhang Li
机构信息
Medical Oncology Department, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People's Republic of China.
Medical Science and Strategy Oncology, Innovent Biologics, Inc., Shanghai, People's Republic of China.
出版信息
J Thorac Oncol. 2020 Dec;15(12):e191-e192. doi: 10.1016/j.jtho.2020.09.028.
PMID:33246599
Abstract
摘要
Zotero 插件